Insiders / Decheng Capital China Life Sciences USD Fund III, L.P.
Decheng Capital China Life Sciences USD Fund III, L.P.
CIK 1736814personinsider
Companies
3
First seen
Sep 21, 2021
Last activity
Oct 20, 2025
Securities
3 companies · 3 positionsView all →
| Company / security | Shares held | Latest |
|---|---|---|
| Cue Health Inc. · HLTH | 8,192,468 | — |
| Common stock | 8,192,468 | Sep 28, 2021 |
| Nivalis Therapeutics, Inc. · ALPN | 7,942,924 | — |
| Common stock | 7,942,924 | Jan 18, 2024 |
| BeyondSpring Inc. · BYSI | 4,028,036 | — |
| Ordinary shares | 4,028,036 | Oct 17, 2025 |
Ownership percentages elsewhere on the site count common and ordinary shares only, because that is what shares outstanding are measured in. Everything above is a real holding; not all of it is a share of the company.
Activity
InsidersInstitutions
This person's trades in company stock, across every company.| Date | Action | Company | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|
| Jan 18, 2024 | Exercise In-the-money exercise | ALPN Nivalis Therapeutics, Inc. Common Stock | $15.73M | +1.2M +23.09% | 6,582,380 | low |
| Sep 17, 2021 | Buy Open-market buy | ALPN Nivalis Therapeutics, Inc. Common Stock | $14.50M | +1.5M +48.73% | 4,708,288 | high |
| Sep 23, 2022 | Grant Grant or award | ALPN Nivalis Therapeutics, Inc. Common Stock | $10.00M |